Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence True

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Human Pathology|July 17, 2020
Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profilingYajuan J Liu, Cigdem Ussakli, Tatjana Antic, et al.
Brachytherapy|November 10, 2004
Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancerTracy Sherertz, Kent Wallner, Gregory Merrick, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trialAndrew Herstein, Kent Wallner, Gregory Merrick, et al.
Nature Medicine|August 7, 2012
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16BYu Sun, Judith Campisi, Celestia Higano, et al.
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
The Journal of Urology|May 24, 2016
Comparative Effectiveness of a Patient Centered Pathology Report for Bladder Cancer CareMatthew Mossanen, Liam C Macleod, Alice Chu, et al.
Oncogene|October 3, 2020
De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-MycOh-Joon Kwon, Li Zhang, Deyong Jia, et al.
Human Pathology|November 29, 2017
Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complexSean R Williamson, Jason L Hornick, John N Eble, et al.
Research Square|July 16, 2024
A Comparative Study of Histotripsy Parameters for the Treatment of Fibrotic ex-vivo Human Benign Prostatic Hyperplasia TissueYashwanth Nanda Kumar, Zorawar Singh, Yak-Nam Wang, et al.
Scientific Reports|September 2, 2024
A comparative study of histotripsy parameters for the treatment of fibrotic ex-vivo human benign prostatic hyperplasia tissueYashwanth Nanda Kumar, Zorawar Singh, Yak-Nam Wang, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Human Pathology|July 17, 2020
Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profilingYajuan J Liu, Cigdem Ussakli, Tatjana Antic, et al.
Brachytherapy|November 10, 2004
Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancerTracy Sherertz, Kent Wallner, Gregory Merrick, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trialAndrew Herstein, Kent Wallner, Gregory Merrick, et al.
Nature Medicine|August 7, 2012
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16BYu Sun, Judith Campisi, Celestia Higano, et al.
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
The Journal of Urology|May 24, 2016
Comparative Effectiveness of a Patient Centered Pathology Report for Bladder Cancer CareMatthew Mossanen, Liam C Macleod, Alice Chu, et al.
Oncogene|October 3, 2020
De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-MycOh-Joon Kwon, Li Zhang, Deyong Jia, et al.
Human Pathology|November 29, 2017
Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complexSean R Williamson, Jason L Hornick, John N Eble, et al.
Research Square|July 16, 2024
A Comparative Study of Histotripsy Parameters for the Treatment of Fibrotic ex-vivo Human Benign Prostatic Hyperplasia TissueYashwanth Nanda Kumar, Zorawar Singh, Yak-Nam Wang, et al.
Scientific Reports|September 2, 2024
A comparative study of histotripsy parameters for the treatment of fibrotic ex-vivo human benign prostatic hyperplasia tissueYashwanth Nanda Kumar, Zorawar Singh, Yak-Nam Wang, et al.
Pageof 6